TRI-CITY AREA — The long journey to recovery for one-year-old Mark Alan Michael Rogers is one he and his family are not walking alone. Hundreds, if not thousands, of people continue to lift the family ...

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

A MUM was left screaming in agony in A&E for 14 hours straight and has been left housebound by an undiagnosed condition.

Withdrawal symptoms can vary depending on the antidepressant, and strategies for tapering off the medication may help.

A doctor on BBC's Morning Live spoke about the surprising medical effects of drinking tonic water. Dr Xand appeared on a ...

GLP1 receptor agonists are widely prescribed to help control blood sugar levels and support weight loss. While these medications can be highly effective, they often come with gastrointestinal side ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission.

The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking non-opioid analgesic designed to treat moderate to severe acute pain ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

But a new non-opioid pain medication, which was just approved by the FDA ... Some of the drug's most common side effects include itching, muscle spasms, and rash.

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.